Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker Administration before primary PCI in patients with ST-elevation Myocardial Infarction trial

American Heart Journal

Volumn 168, Issue 5, 2014, Pages 661-666

  Roolvink, Vincent ^a   Rasoul, Saman ^a   Ottervanger, Jan Paul ^a   Dambrink, Jan Henk E ^a   Lipsic, Erik ^b   Van Der Horst, Iwan C C ^b   De Smet, Bart ^c   Kedhi, Elvin ^a   Marcel Gosselink, A T ^a   Piek, Jan J ^d   Sanchez Brunete, Vicente ^e   Ibanez, Borja ^f,g   Fuster, Valentin ^f,g,h   Van'T Hof, Arnoud W J ^a  

^a ISALA HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c MEANDER MEDICAL CENTER   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e Servicio de Urgencia Medica de Madrid SUMMA 112   (Spain)

^f CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^g HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; METOPROLOL; PLACEBO; TICAGRELOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; DOUBLE BLIND PROCEDURE; EARLY INTERVENTION; HEALTH CARE QUALITY; HEART INFARCTION SIZE; HEART MUSCLE NECROSIS; HOSPITAL ADMISSION; HUMAN; MULTICENTER STUDY (TOPIC); NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STUDY DESIGN; CLINICAL TRIAL; CONTROLLED STUDY; HEART MUSCLE; HEART VENTRICLE REMODELING; INTRAVENOUS DRUG ADMINISTRATION; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; MYOCARDIAL INFARCTION; NECROSIS; PATHOLOGY; PROCEDURES; TIME; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; ADRENERGIC BETA-ANTAGONISTS; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; EARLY MEDICAL INTERVENTION; HUMANS; MAGNETIC RESONANCE IMAGING; METOPROLOL; MYOCARDIAL INFARCTION; MYOCARDIUM; NECROSIS; PERCUTANEOUS CORONARY INTERVENTION; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 84908383399     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.07.015     Document Type: Article

References (25)

1. M.L. Fokkema, S.K. James, and P. Albertsson Population trends in percutaneous coronary intervention: 20-year results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) J Am Coll Cardiol 61 12 2013 1222 1230
2. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardia Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
3. The CAPRICORN Investigators Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial Lancet 357 2001 1385 1390
4. G.Z. Feuerstein, T.L. Yue, and H.Y. Cheng Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity J Hypertens Suppl 11 1993 S41 S48
5. H. Hammerman, R.A. Kloner, and L.L. Briggs Enhancement of salvage of reperfused myocardium by early beta-adrenergic blockade (timolol) J Am Coll Cardiol 3 1984 1438 1443
6. M.M. Rasmussen, K.A. Reimer, and R.A. Kloner Infarct size reduction by propranolol before and after coronary ligation in dogs Circulation 56 1977 794 798
7. K.B. Kern, R.W. Hilwig, and A. Warner Failure of intravenous metoprolol to limit acute myocardial infarct size in a nonreperfused porcine model Am Heart J 129 1995 650 655
8. R. Lange, M.S. Nieminen, and R.A. Kloner Failure of pindolol and metoprolol to reduce the size of nonreperfused infarcts in dogs using area at risk techniques Cardiovasc Res 18 1984 37 43
9. F. Van de Werf, J. Vanhaecke, and I.K. Jang Reduction in infarct size and enhanced recovery of systolic function after coronary thrombolysis with tissue-type plasminogen activator combined with beta-adrenergic blockade with metoprolol Circulation 75 1987 830 836
10. Metoprolol in Acute Myocardial Infarction (MIAMI) A randomized placebo-controlled international trial: the MIAMI Trial Research Group Eur Heart J 6 1985 199 226
11. J. Herlitz, F. Waagstein, and J. Lindqvist COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Addition of clopidogrel to aspirin in 45852 patients with acute myocardial infarction: randomized placebo-controlled trial. Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure Am J Cardiol 80 1997 40J 44J
12. B. Ibanez, C. Macaya, and V. Sanchez-Brunete Effect of early metoprolol on infarct size in ST-segment elevation myocardial infarction patients undergoing primary PCI: the METOCARD-CNIC Trial Circulation 128 2013 1495 1503
13. M. Hirschl, C. Wollmann, and F. Erhart Benefit of immediate beta-blocker therapy on mortality in patients with ST-segment elevation myocardial infarction Crit Care Med 41 2013 1396 1404
14. K. Hanada, T. Higuma, and F. Nishizaki Randomized study on the efficacy and safety of landiolol, an ultra-short-scting β1-adrenergic blocker, in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention Circ J 76 2012 439 445
15. The International Collaborative Study Group Reduction of infarct size with the early use of timolol in acute myocardial infarction N Engl J Med 310 1984 9 15
16. T. Peter, M.K. Heng, and B.N. Singh Failure of high doses of propranolol to reduce experimental myocardial ischemic damage Circulation 57 1978 534 540
17. R.E. Rude, L.M. Buja, and J.T. Willerson Propranolol in acute myocardial infarction: the MILIS experience Am J Cardiol 57 1986 38F 42F
18. S. Yusuf, P. Sleight, and P. Rossi Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction Circulation 67 1983 I-32 I-41 [Suppl]
19. B. Ibanez, V. Fuster, and C. Macaya Study design for the effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion" (METOCARD-CNIC): a randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction Am Heart J 164 2012 473-80.e5
20. E. Wu, J.T. Ortiz, and P. Tejedor Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study Heart 94 2008 730 736
21. D. Atar, P. Petzelbauer, and J. Schwitter Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial J Am Coll Cardiol 53 2009 720 729
22. Randomized trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1: First International Study of Infarct Survival Collaborative Group Lancet 2 1986 57 66
23. B. Ibanez, G. Cimmino, and S. Prat-González The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion Int J Cardiol 147 2011 428 432
24. B. Ibanez, S. Prat-Gonzalez, and W.S. Speidl Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance Circulation 115 2007 2909 2916
25. G. Pizarro, L. Fernandez-Friera, and V. Fuster Long term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial J Am Coll Cardiol 63 2014 2356 2362